All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Humanized mouse models serve as a valuable tool for the development of cancer therapy. They offer a more dependable comprehension of intricate therapeutic interventions. Nowadays, the humanized mouse model has evolved to have a more complete human immune system, which delivers more convenience in cancer therapy. However, mismatched tumors and immune systems hinder the application of these humanized mouse models in evaluating most immunotherapies. Therefore, there is an urgent need to develop personalized humanized mouse models to evaluate different drugs and immunotherapies.
Fig. 1 Precise Treg-based cancer immunotherapies are developed using HIS mouse models.1
Creative Biolabs specializes in providing personalized humanized mouse models for CART in vivo testing. We provide numerous types of specially personalized humanized mouse models targeting diverse therapeutic intents for customers to meet your diverse needs. Simultaneously, we deliver a set of complete experiments to examine animal models for global customers. Furthermore, we are confident in providing customized development solutions if customers have specific target needs. At Creative Biolabs, we have great confidence in presenting an ideal personalized humanized mouse model to serve as a useful tool in achieving your projects.
Fig. 2 Models of peritoneal carcinomatosis in mice.2
Here we list some successful cases in personalized humanized mouse models:
We provide several well-developed ready-to-use personalized humanized mouse models for customers to support your diverse projects:
Models | Modification | Application |
NSG hIL2-high | High expression of IL-2. | Used to validate Tils, TCR-T, and solid tumor CAR-T. |
NSG hIL2-low | Lowly expression of IL-2. | Tregs reconstitution in vivo. |
NSG GM3 | Overexpression of GM-CSF and IL3. | Myeloid cell reconstruction; AML (PDX), CAR-Mac in vivo growth. |
NSG hIL6 | Endogenously expression of IL-6. | Macrophage development; MM(PDX) in vivo growth. |
NSG hIL15-high | High expression of IL-15. | Reconstitution of ADCC, CAR-NK, and iPS-CAR-NK in vivo |
NSG hIL15-low | Lowly expression of IL-15. | Reconstitution of ADCC and CD34-NK. |
NSG HLA A2 | Fusion expression of human B2m and HLA A2. | The growth and maturation of human T cells. |
NSG FLT3 KO / FLT3L |
Knockout of endogenous FLT3; Humanized of FLT3LG. |
The development of the myeloid and dendritic cells. |
NSG hCD47 | Humanization of CD47. | Inhibition of anemia associated with human myeloid to prolong their lifespan. |
NSG FcyR KO | Knockout of murine FcyRI, Il, Ill, and IV. |
Knockout of endogenous ADCP; Enhance the reliability of antibody studies. |
NSG MHC-I KO | Knockout of mouse H-2Db and H-2Kd. | Reduction of the GVHD in PBMC mouse. |
NSG mTslp | Overexpression of mouse Tslp. | The development of lymph nodes. |
NSG LTi (IL2Ry) | Expression of IL2Ry in LTi cells. | The development of lymph nodes. |
NSG hHER2 | Humanization of HER2. | Off-target cytotoxicity of HER2-targeted drugs (CAR-TADC). |
HSC NSG Plus3 | Triple expression of IL3, GMCSF, and IL15. | Reconstitution of the complete immune system (TB, NK, myeloid). |
BRG hCD40 | Humanization of CD40 in BRG. | Examination of CAR-T cytokine storm. |
hCD3 EDG | Humanization of CD3(EDG) gene cell surface region. | Bispecific antibodies targeting CD3. |
hFcyR | In situ humanization of the mouse FcvR locus. | Research and development of therapeutic antibodies. |
hFcRn / HSA | Humanization of FcRn and serum albumin. | In vivo metabolism assay of antibody- and HSA-related long-acting drugs. |
If you want to know more about our personalized humanized mouse models for CART in vivo testing, please contact us.
References
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION